Peer reviewers from low- and middle-income countries(LMIC) for open access journals in oncology can improve the equity in cancer research and clinical trials.

Autor: Mohanti BK; KIMS Cancer Centre, Kalinga Institute of Medical Sciences(KIMS), K.I.I.T. University, Bhubaneswar 751024, Odisha, India. Electronic address: drbkmohanti@gmail.com., Munshi A; Department of Radiation Oncology, ManipalHospitals, Human Care Medical Charitable Trust, Delhi 110075, India. Electronic address: anusheel8@gmail.com., Sarkar B; Apollo Multispecialty Hospital, Kolkata 700054, India. Electronic address: biplabphy@gmail.com., Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, Delhi 110029, India. Electronic address: atul1@hotmail.com., Deo SV; Department of Surgical Oncology, All India Institute of Medical Sciences, Delhi 110029, India. Electronic address: svsdeo@yahoo.co.in.
Jazyk: angličtina
Zdroj: Journal of cancer policy [J Cancer Policy] 2023 Jun; Vol. 36, pp. 100419. Date of Electronic Publication: 2023 Mar 13.
DOI: 10.1016/j.jcpo.2023.100419
Abstrakt: Open access journals (OAJ) in biomedicine are promoted to improve the reach and distribution of global health research (GHR). However, in the last 20 years, article publishing charge (APC) is attracting and publishing the vast majority of papers from high-income countries (HIC) in "oncology" journals under OAJ. This paper outlines the impediments for cancer research and publication from low-and middle-income countries (LMIC): (a) existing disparities in cancer care facilities and survival outcomes between HIC and LMIC, (b) more than 70 % of OAJ in 'oncology' subject levy APC, becoming unaffordable for scientists and clinicians from LMIC, (c) impactful OAJ in oncology engage less than 10 % of members from LMIC in editorial board or as peer reviewer, whereas two-third of cancer diagnosis and management occur in these countries. Peer review serves the editors by recommending the relevant papers. Thus, peer reviewers from developing countries working for the OAJs in "oncology" can increase the diversity in publication, improving the GHR in cancer management. The cancer research and clinical trials which can bring to notice the challenges and hurdles faced by researchers, clinicians and cancer patients in LMIC will be served to some measure by engaging peer reviewers from those countries who understand the ecosystem.
(Copyright © 2023 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: